Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IFF Nutrition & Biosciences, formerly known as DuPont Nutrition & Biosciences, is a global leader in the development of high-value ingredients and bioscience solutions for the food, beverage, dietary supplement, and pharmaceutical industries. The company specializes in probiotics, enzymes, and pharmaceutical excipients, utilizing advanced biotechnology to address global health and wellness needs. Their portfolio features industry-leading brands such as HOWARU probiotics and METHOCEL cellulose ethers, which are essential for advanced drug delivery and clinical nutrition. Following its 2021 merger with International Flavors & Fragrances (IFF), the division continues to leverage its extensive R&D capabilities to innovate in the human microbiome and sustainable health solutions. The company operates globally, providing science-based solutions that enhance the efficacy and delivery of both nutritional and pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DuPont Nutrition.